AUA 2025

AUA Annual Meeting 2025
Date: April 26-29, 2025
Location: Las Vegas, NV


Embracing the Future: The Power of Innovation in a Changing World
Keynote Speaker: Dr. Patrick Soon-Shiong


The Power of ANKTIVA to Overcome Lymphopenia Through NK & Memory T Cells to Achieve Durable Responses in Urological Diseases -Duration Matters
Keynote Speaker: Dr. Patrick Soon-Shiong

Contact us at

+1-844-MY NK CELLS (+1-844-696-5235)

Solutions for Patients

ImmunityBio creates targeted, personalized immunotherapies that are designed to strengthen the immune system and enable it to outsmart your disease.

Opportunities for Trial Investigators

Next-generation adenovirus-vectored anti-cancer vaccines make appealing therapeutics for testing by trial investigators who want to make a contribution to clinical cancer research.

Tools for Research Scientists

Our NK-92® easy-to-maintain and highly cytotoxic natural killer cell line provides a versatile bioanalytical testing tool that can help researchers develop functional killing assays that are more consistent and reliable than donor blood and reporter gene assays.

ImmunityBio is continuously pursuing new immunotherapies designed to attack disease by enhancing the patient’s immune system, not weakening it.